Kevin Jung

Kevin Jung is the Head of Global Business division at G2GBIO, where he leads global business development, strategic partnerships and alliance management for the company’s proprietary long-acting drug delivery platform and also pipleline programs developed using its proprietary technology. Prior to joining G2GBIO, he held business development and account management roles at Lonza, managing partnerships with major pharmaceutical companeis in the APAC region. His expertise spans long-acting injectable formulations, peptide and biologics therapeutics, drug delivery technologies, licensing and partnering, CDMO strategy, and cross-border business development. Kevin is particularly focused on advancing long-acting injectable therapies for chronic diseases, with a strong emphasis on innovative formulation strategies that improve treatment adherence and patient outcomes.